MORE►
Ben Lamm
[Image: Chinnawat Ngamsom/iStock]
Here Are the Winners of The Innovation Awards 2023
by Lance Murray | Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District.
Here's a full list of winners and finalists.
by Lance Murray |
Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas.
Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE►
by David Seeley |
Oct 11, 2022
The Central Intelligence Agency has invested in Colossal through its nonprofit VC investment arm, In-Q-Tel, reports The Intercept. Named in honor of Q—the tech genius from the James Bond novels and movies—the VC firm was founded in 1999 to keep U.S. intelligence agencies on the cutting edge of "innovative and impactful technologies coming out of Silicon Valley and beyond."
So why Colossal? "Strategically, it’s less about the mammoths and more about the capability," In-Q-Tel says.
MORE►
by David Seeley |
Oct 3, 2022
In August, Colossal Biosciences announced it is working to "de-extinct" the Tasmanian tiger with the help of an Australian university and “marsupial biobanking.” It didn't take long for the TV show "Jeopardy" to notice—and work it into an answer.
MORE►
Form Bio, named as one of eight Rising Stars to be honored at iC3 2023, announced its launch at the last year's summit. [Photo: John Davidson/Form Bio]
Form Bio Spins Out of Colossal Bioscience to Offer Scientists the ‘Missing Piece’
by Kevin Cummings | Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.
The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE►
by David Seeley |
Aug 16, 2022
Colossal is already working to "de-extinct" the woolly mammoth via a mammoth-elephant hybrid project. Now the Tasmanian tiger—which went extinct nearly 100 years ago due to human hunting—is the second species Colossal is seeking to bring back.
"We’re thrilled to be collaborating with Andrew Pask and the University of Melbourne to restore this amazing animal to Earth," said Ben Lamm, Colossal's co-founder and CEO.
MORE►
by Kevin Cummings |
Mar 21, 2022
What companies are finding funding or having a big exit? From startup investments to grants and acquisitions, Dallas Innovates tracks what’s happening in North Texas money.
MORE►
by Quincy Preston and David Seeley |
Mar 9, 2022
Colossal launched last September with a plan to "de-extinct" the woolly mammoth by using CRISPR genetic engineering to create a mammoth-elephant hybrid.
With a total raise of $75 million to date, the startup aims to
have its first set of mammoth-elephant hybrid calves "in 4 to 6 years," co-founder and CEO Ben Lamm told us. But Colossal's goals extend much further—with the potential "to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare."
MORE►
Colossal Biosciences co-founders Ben Lamm and George Church aim to "de-extinct" the woolly mammoth and other long-lost creatures. [Photo: Colossal]
Dallas’ Ben Lamm and Harvard’s Dr. George Church Plan to ‘De-Extinct’ the Woolly Mammoth With Their Colossal New Startup
by David Seeley | Sep 13, 2021
It's not "Jurassic Park," but it's almost as amazing. Hypergiant founder Ben Lamm is launching a new biosciences and genetics startup—Colossal—with $15 million in private funding. The goal: Use genomics to "de-extinct" the woolly mammoth and re-wild it on the Arctic tundra. Lamm's co-founder, Harvard geneticist Dr. George Church, says this "grand vision" could lead to big opportunities in conservation, biodiversity, carbon sequestration, and more.
MORE►
by Alex Edwards |
May 18, 2021
Software executive Mike Betzer will lead the next phase of Hypergiant's growth, including a rollout of the industry's first system that provides open AI integration for building AI models.
Founder Ben Lamm, who launched Hypergiant from stealth in 2018, will pursue "the most pressing issues of our lifetime": AI for good, climate change, and the positive impact of technology. "This is where the world needs my time and attention," he says.
Founder Ben Lamm, who launched Hypergiant from stealth in 2018, will pursue "the most pressing issues of our lifetime": AI for good, climate change, and the positive impact of technology. "This is where the world needs my time and attention," he says.
MORE►
by Sandra Engelland |
Nov 10, 2020
The Eos Bioreactor, which also has been featured in Popular Mechanics, uses algae to "eat" CO2.
MORE►
by Lauren Hawkins |
Sep 22, 2020
Farooq will also join the Board of Directors and be the GM of Products at the Texas-based startup. The move is expected to set Hypergiant up for accelerated growth.
MORE►
“We’re about to change the world, and we are doing it with an absolutely incredible team of people who know that ‘impossible’ is only a temporary state,” CEO and co-founder Dave Copps says. [Photo: Michael Samples]
Worlds Raises $10M in Series A Funding as Dave Copps’ AI Startup Launches From Stealth
by Quincy Preston | Feb 6, 2020
The startup, spun out of Hypergiant Sensory Sciences, plans to use the funding to power its "first-of-its-kind" Extended Reality environment, which can be used to build AI-models to give businesses and organizations a new way to view their physical world.
MORE►
by Lance Murray |
Sep 17, 2019
The device, called the Eos Bioreactor, is one of the company’s initial efforts focused on fixing the planet’s environment problems. It captures and stores carbon from the atmosphere.
MORE►
by Alex Edwards |
Jun 26, 2019
With his new role on the Executive Advisory Board, Nye is looking to develop AI systems in two areas he deeply cares about: climate change and space exploration. "We need to think big," he said, "and I'm very optimistic about what AI can do to make the world quite a bit better."
MORE►
by Lance Murray |
Jun 5, 2019
The funding comes roughly a year after Hypergiant launched out of stealth—a year filled with growing revenue (eight figures in the first 12 months), A-list partnerships (Microsoft, Adobe, SAP, Booz Allen, Nvidia), and launching three separate businesses under the parent company.
MORE►
